ESSA Pharma Net Income
| EPIXDelisted Stock | USD 0.20 0.00 0.00% |
As of the 3rd of February, ESSA Pharma shows the Market Risk Adjusted Performance of (1.32), standard deviation of 11.4, and Mean Deviation of 4.85. ESSA Pharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
ESSA Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing ESSA Pharma's valuation are provided below:ESSA Pharma does not now have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. ESSA |
Search Suggestions
| EP | Empire Petroleum Corp | Company |
| EP-PC | El Paso Energy | Company |
| EPASX | Ep Emerging Markets | Mutual Fund |
| EPI | WisdomTree India Earnings | ETF |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, ESSA Pharma reported net income of (28.54 Million). This is 108.36% lower than that of the Biotechnology sector and 140.75% lower than that of the Health Care industry. The net income for all United States stocks is 105.0% higher than that of the company.
ESSA Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ESSA Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ESSA Pharma could also be used in its relative valuation, which is a method of valuing ESSA Pharma by comparing valuation metrics of similar companies.ESSA Pharma is currently under evaluation in net income category among its peers.
ESSA Fundamentals
| Return On Equity | -0.21 | |||
| Return On Asset | -0.15 | |||
| Current Valuation | (99.33 M) | |||
| Shares Outstanding | 47.31 M | |||
| Shares Owned By Insiders | 5.61 % | |||
| Shares Owned By Institutions | 73.70 % | |||
| Number Of Shares Shorted | 1.35 M | |||
| Price To Earning | (1.12) X | |||
| Price To Book | 0.09 X | |||
| EBITDA | (28.45 M) | |||
| Net Income | (28.54 M) | |||
| Cash And Equivalents | 174.6 M | |||
| Cash Per Share | 3.96 X | |||
| Total Debt | 329.26 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 43.43 X | |||
| Book Value Per Share | 2.45 X | |||
| Cash Flow From Operations | (22.72 M) | |||
| Short Ratio | 0.39 X | |||
| Earnings Per Share | (0.57) X | |||
| Target Price | 1.74 | |||
| Number Of Employees | 35 | |||
| Beta | 1.53 | |||
| Market Capitalization | 9.52 M | |||
| Total Asset | 128.11 M | |||
| Retained Earnings | (208 M) | |||
| Working Capital | 124.26 M | |||
| Current Asset | 10.02 M | |||
| Current Liabilities | 3.63 M | |||
| Annual Yield | 0.88 % | |||
| Net Asset | 128.11 M |
About ESSA Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ESSA Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ESSA Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ESSA Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in ESSA Stock
If you are still planning to invest in ESSA Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ESSA Pharma's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |